SSR 125543

Drug Profile

SSR 125543

Alternative Names: SSR 125543A; SSR-125543

Latest Information Update: 04 Nov 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator sanofi-aventis
  • Class Antidepressants; Anxiolytics; Halogenated hydrocarbons; Thiazines
  • Mechanism of Action Corticotropin releasing factor receptor 1 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Major depressive disorder; Post-traumatic stress disorders

Most Recent Events

  • 28 Apr 2011 Discontinued - Phase-II for Major depressive disorder in Belgium (PO)
  • 28 Apr 2011 Discontinued - Phase-II for Major depressive disorder in Canada (PO)
  • 28 Apr 2011 Discontinued - Phase-II for Major depressive disorder in Chile (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top